Monitoring of omalizumab therapy in children and adolescents

por Steiß, J.O., Schmidt, A., Lindemann, H., Rudloff, S., Staatz, A., Strohner, P., Becher, G. , Nährlich, L., Zimmer, K.P.
Publicado 2018

P083 Clinical progression of SARS-CoV-2 infection in people with cystic fibrosis: a global observational study

por McClenaghan, E., Cosgriff, R., Brownlee, K., Ahern, S., Burgel, P.-R., Byrnes, C.A., Colombo, C., Corvol, H., Cheng, S.Y., Daneau, G., Elbert, A., Faro, A., Goss, C.H., Gulmans, V., Gutierrez, H., de Monestrol, I., Jung, A., Nährlich, L., Kashirskaya, N., Marshall, B.C., McKone, E., Middleton, P.G., Mondejar-Lopez, P., Pastor-Vivero, M.D., Padoan, R., Rizvi, S., Ruseckaite, R., Salvatore, M., Stephenson, A.L., da Silva Filho, L.V.R., Melo, J., Zampoli, M., Abdrakhmanov, O., Harutyunyan, S., Carr, S.B.
Publicado 2021